AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimidin M 1mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Axodin Pharmaceuticals Pvt. Ltd.

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimidin M 1mg/500mg Tablet ER

Diabex Duo 1mg/500mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use, even with controlled blood sugar, is crucial. Discontinuation without medical supervision risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are vital for diabetes control. Hypoglycemia (low blood sugar) is the most prevalent adverse effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential for prevention. Alcohol consumption should be minimized due to its hypoglycemic effect. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring, along with periodic blood tests assessing blood cell counts and liver function, are recommended by your doctor.

Uses of Glimidin M 1mg/500mg Tablet ER

Managing type 2 diabetes

Major Benefits of Glimidin M 1mg/500mg Tablet ER:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing. Consume Glimidin M 1mg/500mg Extended-Release tablets with food.

Common Side effects of Glimidin M 1mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimidin M 1mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimidin M 1mg/500mg Extended-Release tablet whole; do not damage it by chewing, crushing, or breaking. Administer this medication with food.

How Glimidin M 1mg/500mg Tablet ER works:

Glimepiride/Metformin 1mg/500mg Extended-Release Tablets (e.g., Glimidin M) combine the actions of two anti-hyperglycemic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts via multiple mechanisms: decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Glimidin M 1mg/500mg Tablet ER is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glimidin M 1mg/500mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimidin M 1mg/500mg tablets are contraindicated for use while breastfeeding. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimidin M 1mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Consult your physician. This medication is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimidin M 1mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. A low initial dose is typically prescribed for those with mild to moderate liver disease; the medication is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glimidin M 1mg/500mg Tablet ER :

Should you forget to take a Glimidin M 1mg/500mg Extended-Release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimidin M 1mg/500mg Tablet ER

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glimidin M 1mg/500mg Tablet ER

Store this medication in its original, tightly sealed container or packaging, following all storage guidelines provided on the label or packaging insert. Discard any remaining medication after use. Prevent access by children, pets, and other individuals.
Glimidin M 1mg/500mg Tablet ER can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more likely in individuals with kidney impairment, the elderly, or those who consume significant alcohol. Symptoms may encompass muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms appear, discontinue Glimidin M 1mg/500mg Tablet ER immediately and seek urgent medical attention.
Glimepiride/Metformin extended-release tablets (1mg/500mg) combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This dual therapy enhances glycemic control when coupled with a balanced diet and physical activity. Glimepiride stimulates pancreatic insulin secretion, thus reducing blood glucose. Metformin acts by decreasing hepatic glucose production and increasing insulin sensitivity. This combination is unsuitable for type 1 diabetes mellitus.
Glimidin M 1mg/500mg Extended-Release tablets may cause common adverse reactions including low blood glucose, taste disturbances, nausea, abdominal discomfort, diarrhea, and cephalalgia. Rare but potentially severe side effects such as lactic acidosis are also possible. Prolonged administration may result in vitamin B12 deficiency.
Prolonged use of Glimidin M 1mg/500mg Extended-Release tablets can lead to Vitamin B12 deficiency. This medication impairs Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications such as paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and ataxia. Preventive strategies proposed by some researchers include annual supplemental Vitamin B12 administration.
Indeed, Glimidin M 1mg/500mg Extended-Release Tablets can lead to hypoglycemia. Low blood sugar may manifest as nausea, headache, irritability, hunger pangs, sweating, lightheadedness, a rapid pulse, and feelings of anxiety or tremor. This risk increases with missed or delayed meals, alcohol consumption, excessive physical activity, or concurrent use of other diabetes medications. Consequently, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, is recommended.
Consuming alcohol concurrently with Glimidin M 1mg/500mg Extended-Release tablets is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimidin M 1mg/500mg Tabl...
48
MRP 59
18% off